Aviva’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $425K | Sell |
19,568
-7,868
| -29% | -$171K | ﹤0.01% | 845 |
|
|
2025
Q1 | $665K | Sell |
27,436
-724
| -3% | -$17.6K | ﹤0.01% | 649 |
|
|
2024
Q4 | $588K | Sell |
28,160
-3,719
| -12% | -$77.6K | ﹤0.01% | 715 |
|
|
2024
Q3 | $634K | Sell |
31,879
-7,303
| -19% | -$145K | ﹤0.01% | 770 |
|
|
2024
Q2 | $607K | Sell |
39,182
-1,975
| -5% | -$30.6K | ﹤0.01% | 771 |
|
|
2024
Q1 | $656K | Sell |
41,157
-1,977
| -5% | -$31.5K | ﹤0.01% | 765 |
|
|
2023
Q4 | $725K | Buy |
+43,134
| New | +$725K | ﹤0.01% | 725 |
|
|
2022
Q1 | – | Sell |
-386,085
| Closed | -$2.61M | – | 1070 |
|
|
2021
Q4 | $2.61M | Buy |
386,085
+59,700
| +18% | +$404K | 0.01% | 769 |
|
|
2021
Q3 | $1.73M | Buy |
+326,385
| New | +$1.73M | 0.01% | 787 |
|